Recent

% | $
Quotes you view appear here for quick access.

Rosetta Genomics, Ltd. Message Board

  • techno_geek_forever techno_geek_forever Jun 20, 2013 10:57 AM Flag

    Like any new product

    It takes time for the word to get out. If you really want to effectively treat cancer, you need to know the tumor type of origin.

    When the word does get out, the doctors are going to love ROSG.

    Don't plan on selling 1 of my 50,000 shares anytime soon!

    Sentiment: Strong Buy

    SortNewest  |  Oldest  |  Most Replied Expand all replies
    • true story just wait for the headline "new pharma partnership"

    • Since when do investors wait for a product to be sold before bidding up share price? Investing is always about anticipating the future. Otherwise, how do you account for the IPO and all of the secondaries? They didn't have a product and still the price was higher. Now that they have a product and are supposedly nearing the goal line, investors are ignoring the stock. Clearly the sentiment has changed.

      This is not unique to ROSG. Check the history of DNDN. Price was at the high when their cancer drug was approved and since has lost 75% since approval and about 95% from the high.

 
ROSG
0.79Feb 11 4:00 PMEST